The Impact of Organokines on Insulin Resistance, Inflammation, and Atherosclerosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Kyung Mook | - |
dc.date.accessioned | 2021-09-04T02:19:36Z | - |
dc.date.available | 2021-09-04T02:19:36Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2016-03 | - |
dc.identifier.issn | 2093-596X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/89430 | - |
dc.description.abstract | Immoderate energy intake, a sedentary lifestyle, and aging have contributed to the increased prevalence of obesity, sarcopenia, metabolic syndrome, type 2 diabetes, and cardiovascular disease. There is an urgent need for the development of novel pharmacological interventions that can target excessive fat accumulation and decreased muscle mass and/or strength. Adipokines, bioactive molecules derived from adipose tissue, are involved in the regulation of appetite and satiety, inflammation, energy expenditure, insulin resistance and secretion, glucose and lipid metabolism, and atherosclerosis. Recently, there is emerging evidence that skeletal muscle and the liver also function as endocrine organs that secrete myokines and hepatokines, respectively. Novel discoveries and research into these organokines (adipokines, myokines, and hepatokines) may lead to the development of promising biomarkers and therapeutics for cardiometabolic disease. In this review, I summarize recent data on these organokines and focus on the role of adipokines, myokines, and hepatokines in the regulation of insulin resistance, inflammation, and atherosclerosis. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ENDOCRINE SOC | - |
dc.subject | KOREAN SARCOPENIC OBESITY | - |
dc.subject | ACID-BINDING PROTEIN | - |
dc.subject | ENDOPLASMIC-RETICULUM STRESS | - |
dc.subject | FATTY LIVER-DISEASE | - |
dc.subject | FETUIN-A | - |
dc.subject | METABOLIC SYNDROME | - |
dc.subject | SELENOPROTEIN P | - |
dc.subject | MEDIATED INHIBITION | - |
dc.subject | HEPATIC STEATOSIS | - |
dc.subject | CTRP FAMILY | - |
dc.title | The Impact of Organokines on Insulin Resistance, Inflammation, and Atherosclerosis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Kyung Mook | - |
dc.identifier.doi | 10.3803/EnM.2016.31.1.1 | - |
dc.identifier.scopusid | 2-s2.0-84962703945 | - |
dc.identifier.wosid | 000407801900001 | - |
dc.identifier.bibliographicCitation | ENDOCRINOLOGY AND METABOLISM, v.31, no.1, pp.1 - 6 | - |
dc.relation.isPartOf | ENDOCRINOLOGY AND METABOLISM | - |
dc.citation.title | ENDOCRINOLOGY AND METABOLISM | - |
dc.citation.volume | 31 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 6 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002092046 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.subject.keywordPlus | KOREAN SARCOPENIC OBESITY | - |
dc.subject.keywordPlus | ACID-BINDING PROTEIN | - |
dc.subject.keywordPlus | ENDOPLASMIC-RETICULUM STRESS | - |
dc.subject.keywordPlus | FATTY LIVER-DISEASE | - |
dc.subject.keywordPlus | FETUIN-A | - |
dc.subject.keywordPlus | METABOLIC SYNDROME | - |
dc.subject.keywordPlus | SELENOPROTEIN P | - |
dc.subject.keywordPlus | MEDIATED INHIBITION | - |
dc.subject.keywordPlus | HEPATIC STEATOSIS | - |
dc.subject.keywordPlus | CTRP FAMILY | - |
dc.subject.keywordAuthor | Insulin resistance | - |
dc.subject.keywordAuthor | Inflammation | - |
dc.subject.keywordAuthor | Atherosclerosis | - |
dc.subject.keywordAuthor | Adipokines | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.